Cargando…

Both resistance- and endurance-type exercise reduce the prevalence of hyperglycaemia in individuals with impaired glucose tolerance and in insulin-treated and non-insulin-treated type 2 diabetic patients

AIMS/HYPOTHESIS: The present study compares the impact of endurance- vs resistance-type exercise on subsequent 24 h blood glucose homeostasis in individuals with impaired glucose tolerance (IGT) and type 2 diabetes. METHODS: Fifteen individuals with IGT, 15 type 2 diabetic patients treated with exog...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Dijk, J.-W., Manders, R. J. F., Tummers, K., Bonomi, A. G., Stehouwer, C. D. A., Hartgens, F., van Loon, L. J. C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3331783/ https://www.ncbi.nlm.nih.gov/pubmed/22124605 http://dx.doi.org/10.1007/s00125-011-2380-5

Ejemplares similares

Exercise Therapy in Type 2 Diabetes: Is daily exercise required to optimize glycemic control?
por: van Dijk, Jan-Willem, et al.
Publicado: (2012)

Should we treat children with hyperglycaemia with insulin after cardiac surgery?
por: Zwart, H, et al.
Publicado: (2009)

Effect of Moderate-Intensity Exercise Versus Activities of Daily Living on 24-Hour Blood Glucose Homeostasis in Male Patients With Type 2 Diabetes
por: van Dijk, Jan-Willem, et al.
Publicado: (2013)

Hyperglycæmia Caused by Prolonged Administration of Insulin
por: Bose, J. P.
Publicado: (1949)

Mealtime fast‐acting insulin aspart versus insulin aspart for controlling postprandial hyperglycaemia in people with insulin‐resistant Type 2 diabetes
por: Bowering, K., et al.
Publicado: (2018)

Prevalence of postprandial hyperglycaemia in basal insulin-treated patients with type 2 diabetes mellitus with controlled fasting glycaemia and elevated glycosylated haemoglobin
por: Tinahones, Francisco J., et al.
Publicado: (2019)

Hyperglycæmia Caused by Prolonged Administration of Insulin
Publicado: (1949)

Lipotoxicity plays a key role in the development of both insulin resistance and muscle atrophy in patients with type 2 diabetes
por: Meex, Ruth C.R., et al.
Publicado: (2019)

The association of hyperglycaemia and insulin resistance with incident depressive symptoms over 4 years of follow-up: The Maastricht Study
por: Geraets, Anouk F. J., et al.
Publicado: (2020)

Suspension of basal insulin to avoid hypoglycemia in type 1 diabetes treated with insulin pump
por: Boronat, Mauro, et al.
Publicado: (2015)

Treating psychological insulin resistance in type 2 diabetes
por: Allen, Nancy A., et al.
Publicado: (2016)

Insulin-induced Lipohypertrophy in Patients with Type 1 Diabetes Mellitus Treated with an Insulin Pump
por: Ucieklak, Damian, et al.
Publicado: (2022)

Efficacy and safety of LY2963016 insulin glargine in patients with type 1 and type 2 diabetes previously treated with insulin glargine
por: Hadjiyianni, I., et al.
Publicado: (2016)

Doses of Insulin and Its Analogues and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
por: Mannucci, Edoardo, et al.
Publicado: (2010)

Lipohypertrophy in Elderly Insulin-Treated Patients With Type 2 Diabetes
por: Gentile, Sandro, et al.
Publicado: (2020)

Liraglutide Treatment in a Patient With HIV and Uncontrolled Insulin-Treated Type 2 Diabetes
por: Diamant, Michaela, et al.
Publicado: (2012)

Perspectives of patients with type 1 or insulin-treated type 2 diabetes on self-monitoring of blood glucose: a qualitative study
por: Hortensius, Johanna, et al.
Publicado: (2012)

Efficacy and tolerability of sitagliptin and metformin compared with insulin as an initial therapy for newly diagnosed diabetic patients with severe hyperglycaemia
por: He, Mingqian, et al.
Publicado: (2021)

Is There Evidence to Support Use of Premixed or Prandial Insulin Regimens in Insulin-Naive or Previously Insulin-Treated Type 2 Diabetic Patients?
por: Yki-Järvinen, Hannele, et al.
Publicado: (2013)

Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trial
por: Rodbard, H W, et al.
Publicado: (2013)

A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes
por: Bergenstal, Richard M., et al.
Publicado: (2012)

African Cuisine-Centered Insulin Therapy: Expert Opinion on the Management of Hyperglycaemia in Adult Patients with Type 2 Diabetes Mellitus
por: Mbanya, Jean Claude, et al.
Publicado: (2020)

Control of diabetic hyperglycaemia and insulin resistance through TSC22D4
por: Ekim Üstünel, Bilgen, et al.
Publicado: (2016)

Metformin and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
por: Monami, Matteo, et al.
Publicado: (2011)

Effect of the Addition of Sitagliptin and Miglitol on Insulin-Treated Type 2 Diabetes
por: Kishimoto, Miyako, et al.
Publicado: (2012)

Cancer Specific Mortality in Insulin-Treated Type 2 Diabetes Patients
por: Ioacara, Sorin, et al.
Publicado: (2014)

Methylglyoxal and insulin resistance in berberine-treated type 2 diabetic patients
por: Memon, Muhammad Ayoob, et al.
Publicado: (2018)

Hypoglycemia in patient with type 2 diabetes treated with insulin: it can happen
por: Heller, Simon R, et al.
Publicado: (2020)

High prevalence of impaired awareness of hypoglycemia and severe hypoglycemia among people with insulin-treated type 2 diabetes: The Dutch Diabetes Pearl Cohort
por: van Meijel, Lian A, et al.
Publicado: (2020)

Diethylnitrosamine Increases Proliferation in Early Stages of Hepatic Carcinogenesis in Insulin-Treated Type 1 Diabetic Mice
por: Arboatti, A. S., et al.
Publicado: (2018)

Use of continuous glucose monitoring in insulin-treated older adults with type 2 diabetes
por: Leite, Silmara A O, et al.
Publicado: (2023)

Partial Sleep Restriction Decreases Insulin Sensitivity in Type 1 Diabetes
por: Donga, Esther, et al.
Publicado: (2010)

Efficacy and safety of alirocumab in insulin‐treated individuals with type 1 or type 2 diabetes and high cardiovascular risk: The ODYSSEY DM‐INSULIN randomized trial
por: Leiter, Lawrence A., et al.
Publicado: (2017)

Usefulness of the insulin tolerance test in patients with type 2 diabetes receiving insulin therapy
por: Okita, Kohei, et al.
Publicado: (2013)

A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes
por: Rosenstock, J., et al.
Publicado: (2008)

Metformin reduces insulin resistance and the tendency toward hyperglycaemia and dyslipidaemia in dogs with hyperadrenocorticism
por: Miceli, Diego Daniel, et al.
Publicado: (2018)

Insulin allergy and resistance successfully treated by desensitisation with Aspart insulin
por: Matheu, Victor, et al.
Publicado: (2005)

Altered hormonal and autonomic nerve responses to hypo- and hyperglycaemia are found in overweight and insulin-resistant individuals and may contribute to the development of type 2 diabetes
por: Lundqvist, Martin H., et al.
Publicado: (2020)

Treating fatty liver and insulin resistance
por: Perry, Rachel J., et al.
Publicado: (2013)

Ambulatory intravenous insulin and islet cell transplantation to treat severe type III insulin hypersensitivity in a patient with type 1 diabetes mellitus
por: Clarke, Brigette, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kfo82cgmvn7u765sne4qnk1if2